Incyte Corporation Stock Takes a Nose Dive After Drug Trial Failure
Stock of the biotechnology company Incyte Corporation (Nasdaq:INCY) have taken a nosedive today after the company released the failed results of their cancer research Phase 3 ECHO-301/KEYNOTE-252 study. >>>Auris Health – Monarch Platform to Revolutionize ... [Read]
Opioids Prescribed Less in States where Medical Marijuana is Legal
Two studies, from the University of Georgia and the University of Kentucky, found that in states where medical marijuana is legal, there was a smaller prescription rate of opioids. The study from the University of ... [Read]
Healthtech That Could Save Lives
Healthtech That Could Save Lives (Sponsored)
There’s a lot of new tech floating around in the health space. Here’s a list of some of the latest gadgets that could help to save lives. Sleep Apnea Smart Watch Sleep apnea is a ... [Read]
Healthtech That Could Save Lives
Healthtech That Could Save Lives (Sponsored)
There’s a lot of new tech floating around in the health space. Here’s a list of some of the latest gadgets that could help to save lives. Sleep Apnea Smart Watch Sleep apnea is a ... [Read]
CVS to Purchase Healthcare Insurance Company Aetna
Breaking news: drugstore chain CVS Health (NYSE:CVS) is purchasing healthcare insurance behemoth Aetna (NYSE:AET). If the proposed deal, which was announced Sunday, is approved, the $69 billion acquisition would wholeheartedly revamp the healthcare sector. Additionally, ... [Read]
Glaukos Corp Lowers Revenue Expectation, 16-Quarter Streak Coming to an End?
Glaukos Corp. (NASDAQ:$GKOS) is a medical device manufacturer with an eye on glaucoma. The company’s shares are plundering 16.7% today, after management made some adjustments to this year’s total revenue expectations. The company’s glaucoma-relieving iStent ... [Read]
Lung Disease Drug Sends Insmed’s Stock Soaring
As of pre-market trading Tuesday, shares of Insmed Inc. (NASDAQ:$ INSM) more than doubled. This came after the company announced that its new drug, an inhaled antibiotic known as Alis, successfully treated patients with a ... [Read]
Shares of Drug Manufacturer Perrigo Co. Increase After Q2 Profit and Revenue Beats
If you’re looking for a drug manufacturer to invest in, you should know that Perrigo Company plc (NYSE:$PRGO) saw its shares increase 12.2% in pre-market trade today. Why? It all started after the company posted ... [Read]
Shares of Synergy Pharmaceuticals are Falling Today and This is Why
On August 10, Synergy Pharmaceuticals (NASDAQ:$SGYP) shares dropped as much as 13% in early morning trade. Why? The commercial-stage biopharmaceutical company reported a much higher loss than what Wall Street was expecting. Even though Synergy ... [Read]
Mylan N.V. Lowers 2017 Forecast Due to Delays in New Drugs
On August 9, American pharmaceutical company Mylan N.V. (NASDAQ:$MYL) announced that delays in launching key new drugs and deteriorating prices for generics in the U.S. will hurt its profitability tremendously in 2017 and 2018. As ... [Read]